about
Canadian practice guidelines for surgical intra-abdominal infectionsTigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-AnalysisEfficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.Acute pancreatitis related to tigecycline: case report and review of the literature.Antimicrobial susceptibilities of Brucella isolates from various clinical specimensModulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?In vitro activity and durability of a combination of an antibiofilm and an antibiotic against vascular catheter colonization.Tigecycline versus levofloxacin in hospitalized patients with community-acquired pneumonia: an analysis of risk factors.Methicillin-resistant Staphylococcus aureus: A public health issue with economic consequences.Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecyclineEfficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized studyIn vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates.
P2860
Q24599288-170CB0E5-3222-4068-AE46-8862A5E68E8EQ26764796-7F7FD785-0F79-4931-AD08-3028F070664DQ33642184-A1385CD4-B7DC-4CCC-9588-3BAD4A0D5CEFQ33816251-26470B65-EF26-43C2-9B69-CD208E018178Q34513298-2EF65907-5CD1-4362-B6A6-94984CA8CF6FQ34599630-E42D99B4-924D-45EF-80C1-92FE45782F88Q34648259-04484005-73E8-4C32-B788-C8B1090D9643Q35142025-1D9FD7E1-596F-4C3C-A193-C3A02AB4FFBDQ35617587-2F9C8F76-CCB5-48DD-A228-A43C56AAA7ABQ36505549-34560CA0-A9F4-406D-93E5-9047BC17FE3FQ36695534-4FB234B1-B2CA-4A3A-9614-46D8844BBD81Q36890997-1E91D03D-7E3F-45A1-AC7A-B5796AC5E9F6Q37119083-19C7D07D-276A-449D-AD5D-335AE3301F6FQ40669465-36749016-5CD0-4C40-89E6-93DBC2916B74Q42549433-B03EC8ED-694C-4892-A809-3DEC6DF1EE3CQ43694841-B234A0E7-8096-4D74-BD0F-8A85FA90A44AQ51482172-DA4208D7-230E-410E-AA10-BAA49B4315E0
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Tigecycline: a novel glycylcycline antibiotic.
@ast
Tigecycline: a novel glycylcycline antibiotic.
@en
type
label
Tigecycline: a novel glycylcycline antibiotic.
@ast
Tigecycline: a novel glycylcycline antibiotic.
@en
prefLabel
Tigecycline: a novel glycylcycline antibiotic.
@ast
Tigecycline: a novel glycylcycline antibiotic.
@en
P2093
P2860
P356
P1476
Tigecycline: a novel glycylcycline antibiotic.
@en
P2093
Daryl J Hoban
Ethan Rubinstein
James A Karlowsky
P2860
P356
10.1586/14787210.4.1.9
P577
2006-02-01T00:00:00Z